MeSH D059413 - intraabdominal infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Amikacin | Amikacin |  | 1994-11-30 |  |  |
| AbbVie | Avibactam, Ceftazidime | Avycaz | 2026-01-07 | 2015-02-25 |  |  |
| Accord Healthcare | Tigecycline | Tigecycline |  | 2018-01-18 |  |  |
| Tigecycline | Tigecycline Accord |  | 2020-04-17 |  |  | |
| Alcon Research | Tobramycin | Tobramycin |  | 1994-05-25 |  |  |
| Alembic Pharmaceuticals | Tobramycin | Tobramycin |  | 2019-04-19 |  |  |
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 |  |  |
| Alkem Laboratories | Tobramycin | Tobramycin |  | 2021-04-01 |  |  |
| Allergan | Ciprofloxacin | Ciprofloxacin |  | 2005-01-21 |  |  |
| Tobramycin | Tobramycin |  | 1989-08-09 |  |  | |
| Altaire Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2018-05-03 |  |  |
| Amneal Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  |
| Tigecycline | Tigecycline | 2033-04-07 | 2018-08-02 |  |  | |
| Tobramycin | Tobramycin |  | 2015-07-13 |  |  | |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 2021-07-15 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
40%2/5
Phase 2
94%15/16
Phase 3
71%34/48
Approved: 15Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use